Invention Grant
- Patent Title: Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy
-
Application No.: US13377091Application Date: 2009-06-09
-
Publication No.: US10024868B2Publication Date: 2018-07-17
- Inventor: Kostantinos (Kostas) Kosmatopoulos , Jeanne Menez-Jamet
- Applicant: Kostantinos (Kostas) Kosmatopoulos , Jeanne Menez-Jamet
- Applicant Address: FR Paris
- Assignee: Vaxon Biotech
- Current Assignee: Vaxon Biotech
- Current Assignee Address: FR Paris
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/IB2009/006332 WO 20090609
- International Announcement: WO2010/143010 WO 20101216
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K38/10 ; A61K38/17 ; C07K7/06 ; C07K14/47 ; G01N33/68 ; G05D16/20 ; G11C13/02
Abstract:
The present invention provides novel methods and materials for efficiently treating patients having an HLA-B*0702 phenotype, based on peptides representing shared epitopes of tumor antigens. In particular, the invention relates to a method for identifying a HLA-B*0702-restricted peptide which can trigger a cytotoxic response against several antigens from one single multigenic family, and to several such epitopes.
Public/Granted literature
- US20120142894A1 Identification, Optimization and Use of Shared HLA-B*0702 Epitopes for Immunotherapy Public/Granted day:2012-06-07
Information query
IPC分类:
